pyrazolo(3,4-d)pyrimidine has been researched along with Lymphoma, T-Cell in 1 studies
*Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoni, F; Botta, M; Crespan, E; Fallacara, AL; Gaudio, E; Greco, C; Iovenitti, G; Kissova, M; Maga, G; Mori, M; Musumeci, F; Passannanti, R; Schenone, S; Spriano, F; Tarantelli, C | 1 |
1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.
Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lymphoma, T-Cell; Molecular Structure; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fyn; Pyrazoles; Pyrimidines; src-Family Kinases; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |